Universe Pharmaceuticals INC financial data

Symbol
UPC on Nasdaq
Location
265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone, Ji'an, Jiangxi, China
Fiscal year end
September 30
Latest financial report
20-F - Q3 2024 - Apr 29, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 23.6M shares +549%
Common Stock, Shares, Outstanding 42.9K shares
Common Stock, Value, Issued 482K USD +610%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 12.9M USD +17.2%
Inventory, Net 1.74M USD -48%
Assets, Current 51.6M USD +104%
Deferred Income Tax Assets, Net 599K USD -55.5%
Property, Plant and Equipment, Net 3.57M USD -3.57%
Intangible Assets, Net (Excluding Goodwill) 263K USD +76.9%
Assets 68M USD +62.9%
Accounts Payable, Current 4.91M USD +7.19%
Liabilities, Current 20.3M USD +47.7%
Liabilities 22.5M USD +63.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.11M USD +53.1%
Retained Earnings (Accumulated Deficit) -10.2M USD -604%
Stockholders' Equity Attributable to Parent 45.5M USD +62.7%
Liabilities and Equity 68M USD +62.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 11.3M shares 0%
Common Stock, Shares, Issued 42.9K shares
Common Stock, Par or Stated Value Per Share 0.02 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.5M USD +458%
Deferred Tax Assets, Gross 599K USD -55.5%
Property, Plant and Equipment, Gross 10.2M USD +4.95%
Deferred Tax Assets, Operating Loss Carryforwards 599K USD -50.5%
Preferred Stock, Shares Authorized 100M shares
Additional Paid in Capital 29.3M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 599K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares